π§ Govt cracks down on GLP-1 drug marketing
The Indian government has tightened surveillance on GLP-1 weight-loss drugs across the country. This move specifically targets the promotion of these medications, banning any surrogate advertising. The regulations come into effect following growing concerns about misleading claims in the market. This action aims to ensure that consumers receive accurate information about these powerful weight-loss aids. Authorities plan to monitor compliance closely over the coming months. π§